EUVIMEDEUVIMED entdecken
Übersichtsarbeit

From pathological mechanisms in Krabbe disease to cutting‐edge therapy: A comprehensive review

Imen Ketata iD, Emna Ellouz iD

Neuropathology · 2024-08 · 44 (4) · 255-277

DOI: 10.1111/neup.12967 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuropathology, online erschienen am 06.03.2024. Verfasst von Imen Ketata und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, University Hospital of Gabes, Gabes, Tunisia. Hauptthemen laut MEDLINE: Leukodystrophy, Globoid Cell. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 148 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since its initial documentation by Knud Krabbe in 1916, numerous studies have scrutinized the characteristics of Krabbe disease (KD) until the identification of the mutation in the GALC gene. In alignment with that, we investigated the natural history of KD spanning eight decades to gain a deeper understanding of the evolutionary trajectory of its mechanisms. Through our comprehensive analysis, we unearthed additional novel elements in molecular biology involving the micropathological mechanism of the disease. This review offers an updated perspective on the metabolic disorder that defines KD. Recently, extracellular vesicles (EVs), autophagy impairment, and α‐synuclein have emerged as pivotal players in the neuropathological processes. EVs might serve as a cellular mechanism to avoid or alleviate the detrimental impacts of excessive toxic psychosine levels, and extracting EVs could contribute to synapse dysfunction. Autophagy impairment was found to be independent of psychosine and reliant on AKT and B‐cell lymphoma 2. Additionally, α‐synuclein has been recognized for inducing cellular death and dysfunction in common biological pathways. Our objective is to assess the effectiveness of advanced therapies in addressing this particular condition. While hematopoietic stem cells have been a primary treatment, its administration proves challenging, particularly in the presymptomatic phase. In this review, we have compiled information from over 10 therapy trials, comparing them based on their benefits and disadvantage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukodystrophy, Globoid CellHumansalpha-SynucleinAnimalsAutophagyExtracellular Vesicles

Stichwörter der Autor:innen

Krabbe diseaseautophagy impairmentextracellular vesiclesgene therapyhematopoietic stem cell transplantation

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Neurology Department, University Hospital of Gabes, Gabes, Tunisia.
  • Sfax University, Sfax Faculty of Medicine, Sfax, Tunisia.

ORCID-Profile: Imen Ketata, Emna Ellouz

Zitieren

APA

Ketata, I., & Ellouz, E. (2024). From pathological mechanisms in Krabbe disease to cutting‐edge therapy: A comprehensive review. Neuropathology, 44(4), 255-277. https://doi.org/10.1111/neup.12967

Vancouver

Ketata I, Ellouz E. From pathological mechanisms in Krabbe disease to cutting‐edge therapy: A comprehensive review. Neuropathology. 2024;44(4):255-277. doi:10.1111/neup.12967

BibTeX
@article{Ketata2024,
  author = {Ketata, Imen and Ellouz, Emna},
  title = {From pathological mechanisms in Krabbe disease to cutting‐edge therapy: A comprehensive review},
  journal = {Neuropathology},
  year = {2024},
  volume = {44},
  number = {4},
  pages = {255--277},
  doi = {10.1111/neup.12967}
}
Kostenlos starten →